荣昌生物
(688331)
| 流通市值：149.99亿 | | | 总市值：520.87亿 |
| 流通股本：1.62亿 | | | 总股本：5.64亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,070,277,163.56 | 1,273,915,008.95 | 721,718,278.96 | 762,492,395.54 |
| 交易性金融资产 | 109,343,391.25 | 9,171,261.22 | - | - |
| 应收票据及应收账款 | 563,769,492.57 | 549,710,992.32 | 535,574,498.81 | 587,688,671.37 |
| 其中：应收票据 | 201,780,450.58 | 194,385,130.59 | 203,611,667.29 | 204,299,928.35 |
| 应收账款 | 361,989,041.99 | 355,325,861.73 | 331,962,831.52 | 383,388,743.02 |
| 应收款项融资 | 66,649,661.83 | 11,880,522.64 | 10,876,421.81 | 11,097,822.85 |
| 预付款项 | 199,387,966.97 | 181,044,440.89 | 211,678,254.07 | 241,373,752 |
| 其他应收款合计 | 50,495,704.79 | 28,447,508.3 | 38,016,784.67 | 24,283,132.94 |
| 存货 | 657,583,963.29 | 641,247,289.43 | 638,250,683.99 | 659,368,730.71 |
| 其他流动资产 | 1,635,532.68 | 2,743,063.99 | 4,672,775.16 | 3,491,867.9 |
| 流动资产合计 | 2,719,142,876.94 | 2,698,160,087.74 | 2,160,787,697.47 | 2,289,796,373.31 |
| 非流动资产: | | | | |
| 长期股权投资 | 11,259,100.76 | 8,737,936.81 | 8,724,070.05 | 8,850,723.9 |
| 其他权益工具投资 | 119,152,359.03 | 94,792,886.55 | 71,451,198.74 | 59,313,437.97 |
| 其他非流动金融资产 | 11,537,475.88 | 5,037,475.88 | 5,037,475.88 | 4,037,475.88 |
| 固定资产 | 2,323,127,608.78 | 2,367,746,020.86 | 2,415,481,681.93 | 2,457,180,322.07 |
| 在建工程 | 535,489,814.61 | 406,420,464.56 | 274,386,452.19 | 283,231,455.78 |
| 使用权资产 | 48,418,068.25 | 62,762,795.54 | 77,016,451.12 | 93,753,714.63 |
| 无形资产 | 154,667,578.99 | 153,902,186.39 | 144,283,335.84 | 143,131,261.71 |
| 长期待摊费用 | 1,599,492.74 | 2,492,190.55 | 3,436,262.42 | 4,324,896.83 |
| 其他非流动资产 | 52,735,508.14 | 50,306,072.04 | 146,740,422.38 | 154,898,506.74 |
| 非流动资产合计 | 3,257,987,007.18 | 3,152,198,029.18 | 3,146,557,350.55 | 3,208,721,795.51 |
| 资产总计 | 5,977,129,884.12 | 5,850,358,116.92 | 5,307,345,048.02 | 5,498,518,168.82 |
| 流动负债: | | | | |
| 短期借款 | 1,071,410,580.8 | 1,320,553,083.34 | 1,131,441,051.38 | 1,083,853,548.13 |
| 应付票据及应付账款 | 194,761,229.05 | 209,201,828.9 | 183,333,479.65 | 162,250,106.68 |
| 应付账款 | 194,761,229.05 | 209,201,828.9 | 183,333,479.65 | 162,250,106.68 |
| 合同负债 | 571,834,427.34 | 1,265,886.69 | 3,464,453.46 | 3,143,688.86 |
| 应付职工薪酬 | 213,004,511.36 | 195,162,276.35 | 202,014,930.29 | 209,986,022.76 |
| 应交税费 | 48,468,857.92 | 30,074,215.92 | 36,662,017.3 | 37,058,544.84 |
| 其他应付款合计 | 320,588,843.38 | 267,878,981.77 | 276,552,827.94 | 314,995,392.79 |
| 一年内到期的非流动负债 | 390,029,409.55 | 508,021,662.64 | 500,378,057.66 | 348,684,938.4 |
| 其他流动负债 | 22,700,635.28 | 15,736,850.57 | 11,108,272.72 | 18,324,410.71 |
| 流动负债合计 | 2,832,798,494.68 | 2,547,894,786.18 | 2,344,955,090.4 | 2,178,296,653.17 |
| 非流动负债: | | | | |
| 长期借款 | 696,200,059.51 | 816,730,338.19 | 1,063,318,088.45 | 1,195,878,046.86 |
| 租赁负债 | 25,274,131.9 | 29,236,692.56 | 33,902,632.34 | 42,093,510.05 |
| 递延收益 | 92,935,766.23 | 91,966,536.39 | 93,744,141.76 | 96,049,337.8 |
| 递延所得税负债 | 9,838,368.16 | 7,039,192.51 | - | - |
| 非流动负债合计 | 824,248,325.8 | 944,972,759.65 | 1,190,964,862.55 | 1,334,020,894.71 |
| 负债合计 | 3,657,046,820.48 | 3,492,867,545.83 | 3,535,919,952.95 | 3,512,317,547.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 563,608,243 | 563,608,243 | 544,332,083 | 544,332,083 |
| 资本公积 | 6,923,757,144.6 | 6,960,504,191.9 | 6,281,946,295.16 | 6,290,989,900.9 |
| 减:库存股 | 262,382,928.1 | 343,271,955.74 | 408,910,121.8 | 445,329,702.16 |
| 其他综合收益 | -32,327,629.91 | -51,910,054.43 | -69,927,500.66 | -81,920,470.23 |
| 未分配利润 | -4,872,571,765.95 | -4,771,439,853.64 | -4,576,015,660.63 | -4,321,871,190.57 |
| 归属于母公司股东权益合计 | 2,320,083,063.64 | 2,357,490,571.09 | 1,771,425,095.07 | 1,986,200,620.94 |
| 股东权益合计 | 2,320,083,063.64 | 2,357,490,571.09 | 1,771,425,095.07 | 1,986,200,620.94 |
| 负债和股东权益合计 | 5,977,129,884.12 | 5,850,358,116.92 | 5,307,345,048.02 | 5,498,518,168.82 |
| 公告日期 | 2025-10-31 | 2025-08-23 | 2025-04-29 | 2025-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |